COMMUNIQUÉS West-GlobeNewswire

Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings

04/11/2024 - 14:00

-- Final CMS rule concludes iovera is a qualifying device for separate payment under the NOPAIN Act -- -- Beginning January 1, 2025, providers can receive additional Medicare payment when they use EXPAREL or iovera ° [...]

Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings

04/11/2024 - 14:00

PONTE VEDRA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12

04/11/2024 - 14:00

DUBLIN, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call [...]

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/11/2024 - 14:00

CHARLESTOWN, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today [...]

Lifeward Streamlines U.S. Operations in Next Phase of Growth and Operational Efficiencies

04/11/2024 - 14:00

Lifeward expects these actions to result in annual operating expense savings of approximately $3 million and gross margin improvement of 200 basis points during 2025 Consolidated real estate footprint will close two U.S [...]

CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025

04/11/2024 - 14:00

MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the Centers for Medicare and Medicaid Services (CMS) assigned the [...]

Alignment Healthcare to Present at UBS Global Healthcare Conference and Stephens Annual Investment Conference

04/11/2024 - 14:00

ORANGE, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the following conferences: UBS Global Healthcare Conference in Rancho Palos Verdes, [...]

Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Hong Kong

04/11/2024 - 14:00

Supports Licensing Partner’s Phase 3 Activities in Acute Heart Failure WARRINGTON, Pa., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology [...]

ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry

04/11/2024 - 14:00

Introduces DNA Expand Subscription Platform to Enrich Existing DNA Ancestry Data with Comprehensive Health Insights GARDEN CITY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or [...]

Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates

04/11/2024 - 14:00

Net product revenue of $83.8 million in 3Q and $250.1 million since launch in August 2023 JNDA for B-VEC filed and on track for commercial launches in Japan and Europe in 2025 French health authority approved pre- [...]

Spectral Medical Provides October Tigris Trial Update

04/11/2024 - 14:00

• 135 patients enrolled TORONTO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic [...]

CervoMed Announces Key Takeaways from Oral Presentations at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD)

04/11/2024 - 14:00

Data from the AscenD-LB Phase 2a trial in DLB confirm recent scientific literature indicating that plasma glial fibrillary acid protein (GFAP) is a robust measure of neurodegenerative disease activity in DLB [...]

HWH International Inc. Launches Hapi Marketplace, a Global B2C Marketplace Platform

04/11/2024 - 14:00

Bethesda, MD, Nov. 04, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (Nasdaq: HWH) is pleased to announce the launch of its proprietary business-to-consumer marketplace, Hapi Marketplace, which aims to offer a [...]

“Share Your Purple Power” This November in Honor of National Epilepsy Awareness Month

04/11/2024 - 14:00

In addition to this year’s theme, the Epilepsy Foundation of America has an exciting new partnership announcement in honor of the awareness month BOWIE, Md., Nov. 04, 2024 (GLOBE NEWSWIRE) -- This November, the Epilepsy [...]

InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services

04/11/2024 - 14:00

DENVER, Nov. 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the [...]

Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference

04/11/2024 - 14:00

HAYWARD, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines [...]

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

04/11/2024 - 14:00

FLORHAM PARK, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) [...]

Allogene Therapeutics Announces Participation in November Investor Conferences

04/11/2024 - 14:30

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for [...]

Vireo Growth Inc. Announces New $10 Million Convertible Debt Facility

04/11/2024 - 14:30

MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), a cannabis company committed to providing safe access, quality products and great value to its [...]